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(57) ABSTRACT 
A system for determination of intraocular pressure includes: 
an intraocular pressure sensor; a light source illuminating 
the sensor with one or more wavelengths of light; and a 
detector that measures emitted light from the sensor. The 
sensor includes a substrate member, a spacer member, and a 
flexible membrane, which define a sealed cavity. The flex-
ible membrane moves in response to intraocular pressure 
changes. A device for measuring intraocular pressure 
includes: the sensor; an anchoring member attached to the 
sensor for immobilizing the sensor in an eye; and a protec-
tive member attached to the anchoring member and covering 
the sensor to prevent contact between the flexible membrane 
and the eye. A method for determination of intraocular 
pressure includes: placing the sensor in an eye; illuminating, 
with a light source, the sensor with one or more wavelengths 
of light; and detecting, with a detector, a resultant light that 
contains information about intraocular pressure. 
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FIG. 13 
Performing a phase calculation on the 
i- interference pattern to determine phase angles 
of the interference pattern 
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SYSTEM, DEVICE, AND METHOD FOR 
DETERMINATION OF INTRAOCULAR 
PRESSURE 
CROSS-REFERENCE TO RELATED 
APPLICATIONS 
This application claims the benefit of U.S. Provisional 
Patent Application No. 61/291,131, filed Dec. 30, 2009, the 
entire disclosure of which is hereby incorporated by refer-
ence 
STATEMENT REGARDING FEDERALLY 
SPONSORED RESEARCH OR DEVELOPMENT 
Subject matter described herein was made with U.S. 
Government support under contract number SBAHQ-08-I-
0081 awarded by the Small Business Administration. The 
government has certain rights in the described subject mat-
ter. 




MATERIAL SUBMITTED ON A COMPACT 
DISC 
Not applicable. 
BACKGROUND OF THE INVENTION 
1. Field of the Invention 
The present invention relates to systems, devices, and 
methods for measuring pressure. More particularly, the 
present invention relates to systems, devices, and methods 
for measuring intraocular pressure. 
2. Background Art 
2 
too large and complex, mostly irreversible, risky with regard 
to biocompatibility, and/or error prone. 
BRIEF SUMMARY OF THE INVENTION 
According to one aspect of the invention, a system for 
determination of intraocular pressure includes: an intraocu-
lar pressure sensor; a light source illuminating the intraocu-
lar pressure sensor with one or more wavelengths of light; 
10 and a detector that measures reflected and/or emitted light 
from the sensor. The intraocular pressure sensor includes a 
substrate member, a spacer member, and a flexible mem-
brane. The substrate member, the spacer member and the 
flexible membrane define a sealed cavity. The flexible mem-
15 brane moves and/or deforms in response to intraocular 
pressure changes. 
In accordance with one implementation, the system fur-
ther includes a processing device in communication with the 
detector. Then, the flexible membrane both transmits and 
20 reflects the one or more wavelengths of light, the substrate 
member reflects the one or more wavelengths of light 
transmitted by the flexible membrane, the light reflected by 
the substrate member interferes with light reflected from the 
flexible membrane to create an interference pattern, and the 
25 interference pattern corresponds to intraocular pressure. 
According to this implementation, the detector is an elec-
tronic imaging device capturing an image of the interference 
pattern, and the processing device performs a phase calcu-
lation on the image of the interference pattern to determine 
30 phase angles of the interference pattern, and correlates the 
phase angles with intraocular pressure. 
The processing device may further perform the phase 
calculation using an integral transform and may calculate the 
phases at one or more spatial frequencies corresponding to 
35 peaks in an absolute value of the integral transform. 
Also, the processing device may use the values of the 
spatial frequencies corresponding to peaks in the absolute 
value of the integral transform to correct for errors which 
arise from angular deviation of a sensor normal from an 
40 optical axis of a readout system. 
Devices that measure intraocular pressure (IOP) by mea-
suring the applanation of the cornea are known in the art. 
Ophthalmologists use such devices to measure IOP in a 
physician's office. However, these single-point measure-
ments remain insufficient to fully manage eye disease, 45 
particularly glaucoma. IOP peaks are missed in office hours 
measurements, IOP fluctuations may be an independent risk 
factor, and a majority of glaucoma patients require changes 
Still further, each wavelength emitted by the light source 
may have a coherence length longer than the twice the 
separation between the flexible membrane and the substrate 
member. 
According to this implementation, the system may further 
include an optical filter positioned between the intraocular 
pressure sensor and at least one of the light source and the 
electronic imaging device. The optical filter provides an 
optical coherence length greater than twice the distance from to their topical and/or surgical management approach after 
multiple IOP measurements on a single day. Infrequent 
measurements also make it difficult to evaluate treatment 
effectiveness and/or to assess patient compliance. However, 
more frequent, longer term tonometry is labor intensive, 
impractical, expensive, and often conducted only upon 
admission to an academic hospital. Tonometers that can be 
used by the patient are know in the art, but these devices 
often cause discomfort, have proven difficult for patients to 
repeatably administer, and have demonstrated unacceptable 
error in clinical studies. 
50 the flexible membrane to the substrate member. 
The light source may be modulated in time to allow for 
lock-in detection of the interference pattern. 
Further, the light source may emit multiple wavelengths 
of light, either simultaneously or sequentially, and the 
55 dimensions of the flexible membrane may allow a phase 
change in the interference pattern of greater than 2it for at 
least one of the multiple wavelengths of light. 
In accord with another implementation, the system further 
includes a processing device in communication with the 
60 detector, a coating containing a fluorescent material coated 
on at least one of the substrate member and the flexible 
Implantable electronic devices for more frequent mea-
surement of intraocular pressure are known in the art. 
Readout of passive electronic sensors has proven problem-
atic because inductively coupling to tiny receivers in the 
sensor is difficult. Active sensors overcome this problem, but 
require implantable power sources or power storage sys- 65 
terns, implanted integrated circuits, and large antennas. As a 
result, both passive and active systems have so far proven 
membrane, and a filter positioned between the intraocular 
pressure sensor and the detector. An external light source 
excites the fluorescent material of the coating, the fluores-
cent material of the coating emits a light of a different 
second wavelength, the emission of the light of the second 
wavelength being the result of excitation of the fluorescent 
US 10,687,704 B2 
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brane from contacting the bottom of the sealed cavity under 
pressures encountered in the intraocular environment. 
material, and the proximity of the flexible membrane to the 
substrate member modulates the intensity of the emitted 
light of a different second wavelength. The detector is a light 
intensity sensor. The filter allows only the second wave-
length to reach the detector. Then, the processing device 
correlates the detected intensity at the second wavelength 
with intraocular pressure. 
Further in accord with this implementation, the materials 
and dimensions of the flexible membrane may limit pressure 
5 measurement errors to less than 1 mm Hg in the presence of 
temperature fluctuations from 32° C. to 36° C. typically 
encountered in the intraocular environment. 
According to another aspect of the invention, a device for 
measuring intraocular pressure includes: an intraocular pres-
sure sensor including a substrate member, a spacer member, 
and a flexible membrane, the substrate member, the spacer 
member and the flexible membrane defining a sealed cavity 
wherein the flexible membrane moves and/or deforms in 
response to intraocular pressure changes; an anchoring 
member attached to the intraocular pressure sensor for 
immobilizing the intraocular pressure sensor in an eye; and 
a protective member attached to the anchoring member and 
covering the intraocular pressure sensor to prevent contact 
between the flexible membrane and portions of the eye. 
Still further in accord with this implementation, the mate-
rial and dimensions of the flexible membrane and the 
10 thickness of the spacer member provide an interference 
pattern without using a light source that relies on laser 
action. 
This implementation may further include a layer of addi-
tional material coated on the external side of the membrane, 
15 with the thickness and refractive index of the additional 
material equalizing the reflection from the flexible mem-
brane and the substrate member. 
Additionally, the material and dimensions of the mem-
brane of this implementation may limit the phase change in 
the interference pattern to less than 2it over a range of 610 
to 820 mmHg absolute pressure. 
In accordance with one implementation, the anchoring 20 
member comprises a plate for insertion in a scleral pocket 
and for immobilizing the device, and an arm for entering an 
anterior chamber of the eye through a scleral tunnel. The 
plate may include holes for suturing the plate to the eye, 
and/or holes for assisting wound healing. 
In accordance with another implementation, the intraocu-
lar pressure sensor includes a coating containing a fluores-
cent material, the coating being coated on at least one of the 
25 substrate member and the flexible membrane. An external 
In accordance with another implementation, the anchor-
ing member includes a pair of pincers to enclavate an iris of 
the eye. 
In accordance with yet another implementation, the 
device further includes a second intraocular pressure sensor 30 
having at least one of a different diameter, shape, membrane 
thickness, membrane material, and substrate material, such 
that the intraocular pressure sensor and the second intraocu-
lar pressure sensor provide at least one of redundant pressure 
measurement, failure detection, compensation for tempera- 35 
ture fluctuations in the eye, increased pressure measurement 
sensitivity, and increased pressure measurement dynamic 
range. 
The anchoring member and the protective member may 
be formed from a biocompatible material selected from a 40 
group consisting of polymethylmethacrylate, other acrylic 
plastics, silicone, other biocompatible plastics, biocompat-
ible metals, and biocompatible metal alloys. 
According to another aspect of the invention, an intraocu-
lar pressure sensor, includes: a substrate member; a spacer 45 
member; and a flexible membrane. The substrate member, 
the spacer member and the flexible membrane define a 
sealed cavity, and the flexible membrane moves and/or in 
response to intraocular pressure changes and the movement 
light source excites the fluorescent material of the coating, 
and the fluorescent material of the coating emits a light of a 
different second wavelength, the emission of the light of the 
second wavelength being the result of excitation of the 
fluorescent material. The proximity of the flexible mem-
brane to the substrate member modulates the intensity of the 
emitted light of a different second wavelength and the 
detected intensity of the emitted light of the different second 
wavelength is used to determine the pressure. 
This implementation may further include a scattering 
medium coated on at least one of the flexible membrane and 
the substrate member. 
Also, in accordance with this implementation, the coating 
may further include a second fluorescent material, and the 
external light source may further excite the second fluores-
cent material of the coating to emit a light of a different third 
wavelength. Then, the difference in detected intensity of the 
emitted light at the second and third wavelengths may be 
used to determine the pressure. 
According to another aspect of the invention, a method for 
determination of intraocular pressure includes placing an 
intraocular pressure sensor in an eye, the intraocular pres-
sure sensor including a substrate member, a spacer member, 
and a flexible membrane, the substrate member, the spacer 
of the flexible membrane can be measured optically. 
In accordance with one implementation, the sealed cavity 
has a pressure below one atmosphere. 
50 member and the flexible membrane defining a sealed cavity 
wherein the flexible membrane moves and/or deforms in 
response to intraocular pressure changes. The method fur-
ther includes illuminating, with a light source, the intraocu-In accordance with another implementation, light is both 
transmitted and reflected by the flexible membrane, and 
reflected by the substrate member, the light reflected by the 55 
substrate member interferes with light reflected from the 
flexible membrane to create an interference pattern, and the 
resulting interference pattern corresponds to intraocular 
pressure. 
According to this implementation, material and dimen-
sions of the flexible membrane may provide a number of 
periods in the interference pattern to estimate phase within 
±0.03 radians such that intraocular pressure can be measured 
with an accuracy of 1 mm Hg over a range of 610 to 820 
mmHg absolute pressure. 
Also according to this implementation, the material and 
dimensions of the flexible membrane may prevent the mem-
lar pressure sensor with one or more wavelengths of light, 
and detecting, with a detector, a resultant light that contains 
information about intraocular pressure. 
In accordance with one implementation, the flexible 
membrane both transmits and reflects the one or more 
wavelengths of light, the substrate member reflects the one 
60 or more wavelengths of light transmitted by the flexible 
membrane, and the light reflected by the substrate member 
interferes with light reflected from the flexible membrane to 
create an interference pattern. The interference pattern cor-
65 
responds to intraocular pressure. 
According to this implementation, detecting the resultant 
light includes capturing, with an electronic imaging device, 
an image of the interference pattern, and the method further 
US 10,687,704 B2 
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includes: performing a phase calculation on the image of the 
interference pattern to determine phase angles of the inter-
ference pattern; and correlating the phase angles with 
intraocular pressure. 
Then, this implementation may further include position- 5 
ing an optical filter between the intraocular pressure sensor 
and at least one of the light source and the electronic 
imaging device, the optical filter providing an optical coher-
ence length greater than twice the distance from the flexible 
membrane to the substrate member. 10 
6 
Other features and advantages of the invention will be set 
forth in, or apparent from, the detailed description of exem-
plary embodiments of the invention found below. 
BRIEF DESCRIPTION OF THE SEVERAL 
VIEWS OF THE DRAWINGS 
These and other features, aspects, and advantages of the 
present invention will become better understood with regard 
to the following description, appended claims, and accom-
panying drawings where: According to this implementation, the step of illuminating 
the intraocular pressure sensor includes modulating the light 
source in time to allow for lock-in detection of the interfer-
ence pattern by the electronic imaging device. 
FIG. 1 is a functional block diagram of an exemplary 
system for determination of intraocular pressure, according 
15 
to the invention; 
FIG. 2A and FIG. 2B are schematic cross-sectional views 
of exemplary intraocular pressure sensors according to the 
invention; 
In accordance with another implementation, the method 
further includes coating a layer containing fluorescent mate-
rial on at least one of the substrate member and the flexible 
membrane. Illuminating the intraocular pressure sensor 
includes exciting the fluorescent material of the coating with 
a light source such that the fluorescent material of the 
coating emits a light of a different second wavelength, the 
emission of the light of the second wavelength being the 
result of excitation of the fluorescent material. Then, the 
proximity of the flexible membrane to the substrate member 
modulates the intensity of the emitted light of a different 
second wavelength. Additionally, detecting the resultant 
light includes detecting an intensity of the emitted light of 
the different second wavelength to determine the pressure. 
FIG. 3A is a representation of an image of an exemplary 
20 interference pattern; 
FIG. 3B is a graph of an absolute value of an integral 
transform of the exemplary interference pattern of FIG. 3A; 
FIG. 3C is a graph of an experimentally measured rela-
tionship between phase of an interference pattern and liquid 
25 pressure for an exemplary intraocular pressure sensor; 
FIG. 4A is another representation of an image of an 
exemplary interference pattern; 
35 
FIG. 4B is a graph of an absolute value of an integral 
transform of the exemplary interference pattern of FIG. 3A; 
FIG. SA is a schematic perspective view of an exemplary 
embodiment of a device for measuring intraocular pressure 
according to the invention; 
FIG. SB is a schematic sectional view of an eye with the 
device of FIG. SA implanted therein; 
FIG. 6A is a schematic plan view of another exemplary 
embodiment of a device for measuring intraocular pressure 
according to the invention; 
In accordance with another implementation, placing the 30 
intraocular pressure sensor in the eye includes immobilizing 
the intraocular pressure sensor in the eye using an anchoring 
member attached to the intraocular pressure sensor. The 
anchoring member may include a plate and an arm, and the 
immobilizing the intraocular pressure sensor in the eye may 
further include: inserting the plate into a scleral pocket of the 
eye; and inserting the arm into an anterior chamber of the 
eye through a scleral tunnel. Also, immobilizing the 
intraocular pressure sensor in the eye may include suturing 
the plate to the eye using holes in the plate. 
FIG. 6B is a schematic plan view of an eye with the device 
40 of FIG. 6A implanted therein; 
According to another aspect of the invention, a method for 
the determination of intraocular pressure uses an interfer-
ence pattern produced by an intraocular pressure sensor. The 
intraocular pressure sensor includes a substrate member, a 
spacer member, and a flexible membrane. The substrate 45 
member, the spacer member and the flexible membrane 
define a sealed cavity; wherein the flexible membrane moves 
and/or deforms in response to intraocular pressure changes. 
The movement or deformation of the flexible membrane is 
FIG. 7A through FIG. 7D are schematic cross-sectional 
views of exemplary intraocular pressure sensors according 
to the invention further comprising a coating containing a 
fluorescent material; 
FIG. SA and FIG. 8B are representations of interference 
patterns having a phase change of 2it; 
FIG. 9A and FIG. 9B are representations of interference 
patterns associated with multiple, sequentially emitted 
wavelengths; 
FIG. 9C and FIG. 9D are graphs of the absolute value of 
integral transforms of the interference patterns of FIG. 9A 
and FIG. 9B, respectively; 
FIG. lOA is a representation of an interference pattern 
associated with multiple, simultaneously emitted wave-
55 lengths; 
measured optically. Light from a light source, emitting one 50 
or more wavelengths of light either simultaneously or 
sequentially, is both transmitted and reflected by the flexible 
membrane, and reflected by the substrate member. The light 
reflected by the substrate member interferes with light 
reflected from the flexible membrane to create an interfer-
ence pattern. The method includes: performing, by a pro-
cessing device, a phase calculation on the interference 
pattern to determine phase angles of the interference pattern, 
and correlating the phase angles with pressure. The phase 
calculation may be performed using an integral transform 
and the phases may be calculated at one or more spatial 
frequencies corresponding to peaks in an absolute value of 
the integral transform. Additionally, values of the spatial 
frequencies corresponding to the peaks in the absolute value 
FIG. 10B is a graph of the absolute value of the integral 
transform of the interference pattern of FIG. lOA; 
FIG. llA through FIG. llD are graphs showing a calcu-
lated ratio of resultant light power to incident light power as 
60 a function of membrane-fluorescent coating separation; 
FIG. 12 is a flow chart of an exemplary method for 
determination of intraocular pressure according to the inven-
tion; 
of the integral transform may be used to correct for errors 65 
which arise from angular deviation of a sensor normal from 
FIG. 13 is a flowchart of an exemplary method for the 
determination of pressure from an interference pattern pro-
duced by an intraocular pressure sensor according to the 
invention; and an optical axis of a readout system. 
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FIG. 14A and FIG. 14B are schematic perspectives view 
of further exemplary embodiments of a device for measuring 
intraocular pressure according to the invention. 
DETAILED DESCRIPTION OF EXEMPLARY 
EMBODIMENTS OF THE INVENTION 
8 
pressure for an intraocular pressure sensor 101 with a silicon 
substrate member 200, a silicon nitride flexible membrane 
202, illuminated with a light emitting diode light source 102 
at a wavelength of similar to 800 nm. 
As shown in FIG. 3B, the processing device 107 (FIG. 1) 
performs the phase calculation using an integral transform 
and calculates the phase at one or more spatial frequencies 
corresponding to peaks 301 in an absolute value of the 
integral transform 302. This calculation further allows for 
FIG. 1 shows an exemplary system 100 for frequent 
measurement of intraocular pressure using an intraocular 
(i.e., inside or within an eye) pressure sensor 101 which, in 
use, would be implanted in an eye. The pressure is measured 
optically by the system 100 using a light source 102 to 
illuminate the intraocular pressure sensor 101 with one or 
more wavelengths of incident light 103. A resultant light 113 
10 correction of pressure readings for angular deviations 
between the optical axes of the detector 106 and the 
intraocular pressure sensor 101, as described in more detail 
below. 
( comprising reflected light or a combination of reflected and 15 
emitted light) is captured by a detector 106 and the signal 
from the detector 106 is processed by a processing device 
107 to determine the intraocular pressure. 
The exemplary system 100 further comprises an objective 
lens 110, a beam splitter 104, an illuminating lens 111, and 20 
a diffuser 112. The objective lens 110 performs at least one 
of the functions of collecting light from the intraocular 
pressure sensor 101 and forming an image of the intraocular 
pressure sensor 101 on the detector 106. The beam splitter 
104 allows light from the source 102 to reach the intraocular 25 
pressure sensor 101 and the reflected light from the intraocu-
lar pressure sensor 101 to reach the detector 106. The 
illuminating lens 111 and diffuser 112 provide well con-
trolled, uniform illumination of the intraocular pressure 
sensor 101. The exemplary system 100 further comprises an 30 
atmospheric pressure sensor 109. The atmospheric pressure 
sensor 109 communicates with the processing device 107 to 
allow measurement of intraocular pressure with respect to 
atmospheric pressure. The atmospheric pressure sensor 109 
can be an optical pressure sensor 101 as described here or 35 
one of several atmospheric pressure sensors known to those 
skilled in the art of pressure measurement. 
FIG. 2A shows an exemplary intraocular pressure sensor 
101 comprising a substrate member 200, a spacer member 
201, and a flexible membrane 202 which define a sealed 40 
cavity 203. The flexible membrane 202 deflects in response 
to changes in intraocular pressure and these changes can be 
measured optically. The incident light 103 is both transmit-
ted and reflected by the flexible membrane 202, and reflected 
by the substrate member 200. The light reflected by the 45 
substrate member 200 interferes either constructively or 
destructively with light reflected from the flexible membrane 
202 such that the resultant light 113 (FIG. 1) comprises an 
interference pattern 300, as shown in FIG. 3A. 
FIG. 4A shows an interference pattern 300 from a sensor 
101 whose optical axis is tilted about the y-axis effectively 
compressing the pattern along the x-direction. 
FIG. 4B, discussed below, shows the absolute value of an 
integral transform 302 of the interference pattern 300. 
In an embodiment each wavelength emitted by the light 
source 102 (FIG. 1) has a coherence length longer than twice 
the separation between the flexible membrane 202 and the 
substrate member 200 (FIGS. 2A and 2B). Having a suffi-
ciently long coherence length ensures that the interference 
pattern 300 (FIG. 3A) can be clearly captured by the detector 
106 (FIG. 1). A shorter coherence length could be contem-
plated, but would reduce the visibility of the interference 
pattern 300 and thus reduce the signal to noise ratio of the 
detector 106 signal. 
In an embodiment the light source 102 is a light emitting 
diode. A light emitting diode is preferred because it emits a 
narrow range of wavelengths such that the coherence length 
of the incident light 103 and resultant light 113 is between 
1 µm and 1000 µm. This is appropriate for the range of 
sealed cavity 203 thicknesses described in more detail 
below. Laser light sources also offer sufficiently long coher-
ence lengths, but light emitting diodes offer greater eye 
safety. 
In the exemplary system 100 shown in FIG. 1, an optical 
filter 105 is positioned between the intraocular pressure 
sensor 101 and at least one of the light source 102 and the 
detector 106. The optical filter 105 increases the coherence 
length of at least one of the incident light 103 and resultant 
light 113. The optical filter 105 is required if the light source 
102 does not have an intrinsically long enough coherence 
length. In a preferred embodiment the filter is positioned 
immediately in front of the detector so as to block other light 
not at the wavelength of the resultant light 113. 
In a preferred embodiment the wavelengths of the inci-
dent light 103 are in the infrared spectral region so that the 
incident light 103 remains invisible to the patient. 
In an embodiment, the light source 102 is modulated in 
time by a modulator 108 which also communicates with the 
processing device 107. The modulator modulates the light 
source by at least one of electrical or mechanical means or 
The interference pattern 300 consists of bright and dark 50 
regions that are referred to as interference fringes. The 
brightest and darkest levels of the interference pattern 300 
are shown as solid and dashed contour lines in FIG. 3A. 
These interference fringes change position when the flexible 
membrane 202 deflects in response to intraocular pressure 
changes as described in more detail below. Thus, the inter-
ference pattern 300 corresponds to intraocular pressure. 
55 some combination of electrical and mechanical means. The 
modulator 108 has a frequency such that many cycles are 
contained in a single intraocular pressure measurement. The 
modulating signal can be any of several periodic signals, 
such as a sine wave or square wave, that are familiar to those 
The interference pattern 300 is captured using the detector 
106 (FIG. 1). In an embodiment the detector 106 is an 
electronic imaging device such as a digital camera or 
photodetector array. In an embodiment, the detector 106 
communicates with a processing device 107 which performs 
a phase calculation on the image of the interference pattern 
300 and correlates the calculated phase angles with intraocu-
lar pressure. 
FIG. 3C shows the experimentally measured relationship 
between the phase of the interference pattern 300 and liquid 
60 skilled in the art. The signal from the modulator 108 is also 
routed to the processing device 107 where it is combined 
with the signal from the detector 106 for phase-locked (or 
"lock-in") detection, a technique well known to those skilled 
in the art of low-level signal measurements. This detection 
65 method reduces noise that could be introduced by light 
sources, for example room lights, other than the resultant 
light 113. 
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unit, a head mounted unit, and an eye glass mounted unit. 
The assembly may or may not contain the light source 102. 
In an embodiment relative motion is limited by providing 
a target at which the patient gazes while the pressure 
In an embodiment the light source 102 emits multiple 
wavelengths of light in order to improve at least one of the 
precision and dynamic range of the pressure measurement. 
This is particularly important for designs of the intraocular 
pressure sensor 101 in which the deflection of the flexible 
membrane 202 yields a phase change of greater than 2it. 
FIG. SA and FIG. 8B show interference patterns 300 
having a phase change of 2it. 
5 measurement is acquired. The target can be real structure or 
a virtual image created using optics within the assembly. 
Those skilled in the art have found that angular motions are 
limited to less than 0.2 degrees during visual fixation. 
In an embodiment an eye cup can be added to the A single wavelength measurement of a single intraocular 
pressure sensor 101 (FIG. 1) would exhibit pressure ambi-
guities if the phase changes by more than 2it, as described 
in more detail below. 
FIG. 9A and FIG. 9B show interference patterns 300 
associated with each wavelength captured by the detector 
106 in an embodiment where multiple wavelengths are 
emitted sequentially. The processing device 107 (FIG. 1) 
calculates the phase angle of each interference pattern 300 at 
spatial frequencies corresponding to the illuminating wave-
lengths as described in more detail below. 
10 assembly containing the detector 106. The eye cup contacts 
the face during the pressure measurement in order to physi-
cally limit movement of the intraocular pressure sensor 101 
with respect to the detector 106. 
In an embodiment, at least one of autofocus mechanisms 
15 or image stabilization mechanisms, familiar to those skilled 
in the art, are added to the assembly to minimize the 
movement of the sensor 101 image and the detector 106. 
In an embodiment the detector 106 is an electronic image 
sensor with a frame rate in excess of 100 frames per second. 
20 The frame rate allows images to be captured during times 
when the sensor is in focus and within the field of view of As shown in FIG. lOA, in an alternative embodiment the 
light source 102 emits the multiple wavelengths simultane-
ously, and a more complex interference pattern 300 is 
generated. The processing device 107 now calculate the 
phase angles from a single interference pattern 300 but at 25 
multiple spatial frequencies, each spatial frequency corre-
sponding to a different wavelength, as described in more 
detail below. 
the electronic image sensor. 
The processing device 107 is preferably at least one of a 
dedicated electronic circuit, a microprocessor, a digital sig-
nal processor, or a programmable logic device. The process-
ing device 107 may be either internal or external to the 
assembly containing the detector 106. The processing device 
is connected to the detector by at least one of a physical 
electrical connection, a wireless connection, or a network In yet another embodiment, as shown in FIG. 7 A and FIG. 
7B respectively, the intraocular pressure sensor 101 further 
comprises a coating 700 containing a fluorescent material, 
the coating 700 being coated on at least one of the substrate 
member 200 and the flexible membrane 202. As used herein, 
30 connection all of which are familiar to those skilled in the 
a fluorescent material is a material which absorbs electro-
magnetic energy of a specific first wavelength and re-emits 35 
energy at different (but equally specific) additional wave-
lengths. A fluorophor is a component, such as a fluorescent 
dye molecule, of a fluorescent material which absorbs elec-
tromagnetic energy of a specific first wavelength and re-
emits energy at different (but equally specific) second wave- 40 
length. A fluorescent material may contain one or more 
fluorophors. The incident light 103 excites the fluorescent 
material of the coating 700, and the fluorescent material of 
the coating 700 emits light of a different second wavelength, 
the emission of the light of the second wavelength being the 45 
result of excitation of the fluorescent material. After passing 
back through the flexible membrane, and perhaps being 
further modulated, the emitted light of a different second 
wavelength becomes the resultant light 113. 
In an embodiment, the proximity of the flexible mem- 50 
brane 202 to the substrate member 200 modulates the 
art. 
FIG. SA shows a device for measuring intraocular pres-
sure comprising an intraocular pressure sensor 101 and an 
anchoring member 500. The anchoring member comprises a 
protective member 501, a plate 502, and an arm 503. 
FIG. 5B shows an eye 505 with the device implanted 
through the sclera 508 such that the intraocular pressure 
sensor 101 is located in the anterior chamber 506 and is 
visible through the cornea 507. The protective member 501 
prevents the intraocular pressure sensor 101 from contacting 
the cornea 507 in case of movement of the sensor toward the 
cornea 507. The dimensions of the plate 502 are chosen so 
that it can be fixed in a scleral pocket. Although other 
dimensions could be contemplated, a long dimension of 1 to 
5 mm and a short dimension of 1 to 3 mm are appropriate. 
In one embodiment the plate 502 contains holes 504 for 
suturing the anchoring member 500 to the sclera 508. 
Although other dimensions could be contemplated, the 
diameter of the holes should be greater than approximately 
50 µm to permit an atraumatic needle and suture to pass. 
In an embodiment the plate 502 contains holes 504 to 
assist in wound healing. In this case the sclera 508 closes 
through the holes to promote both healing and immobiliza-
tion of the device. The dimensions of the arm 503 are such 
intensity of the resultant light 113. In an embodiment the 
intensity of the resultant light 113 from the intraocular 
pressure sensor 101 is modulated based on several phenom-
ena described in more detail below. In an embodiment the 
detector 106 is one or more light intensity sensors. The light 
intensity sensors may be at least one of photodiodes or 
photomultipler tubes. The signal from the detector 106 
corresponds to intraocular pressure, and the processing 
device 107 processes the signal to determine intraocular 
pressure. In an embodiment the optical filter 105 is placed 
between the intraocular pressure sensor 101 and the detector 
106 such that only the second wavelength in the resultant 
light 113 reaches the detector 106. 
55 that the arm can extend through a scleral tunnel placing the 
intraocular pressure sensor 101 in a position within the 
anterior chamber 506 such that the intraocular pressure 
sensor 101 is visible through the cornea 507. Other dimen-
sions could be contemplated, but an arm width of 1 to 2 mm 
60 and an arm length of 2 to 7 mm are acceptable. 
Movement of the intraocular pressure sensor 101 with 65 
respect to the assembly containing the detector 106 must be 
considered. The assembly may be at least one of a handheld 
In an embodiment shown in FIG. 6A and FIG. 6B, the 
anchor member 500 comprises a pair of 600 on at least one 
end such that it can be attached to the iris 601 rather than 
fixed in the sclera 508. In this embodiment the anchor 
member 500 along with the attached intraocular pressure 
sensor 101 is inserted into the anterior chamber 506 and 
placed on the iris 601 such that it does not block the pupil 
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602. The tissue of the iris is enclavated by the pincers 600 
to immobilize the anchor member 500 in the eye 505. 
12 
An exemplary device with two intraocular pressure sen-
sors 101 includes one sensor 101 with diameter similar to 
300 um and flexible membrane thickness similar to 1.5 µm 
and another sensor 101 with flexible membrane 202 diam-
In an embodiment shown in FIG. 14A two or more 
intraocular pressure sensors 101 can be included in the same 
device. This provides redundant pressure measurements that 
increase confidence in the pressure reported by the intraocu-
lar pressure measurement system 100. In addition, if one 
sensor fails, the deviation in readings between the first 
sensor and any additional sensors will serve as an indication 
of the failure. 
5 eter similar to 600 um and flexible membrane 202 thickness 
similar to 200 nm. The sensitivity of the two sensors 101 to 
changes in pressure are 0.020 radians/mmHg and 0.074 
radians/mmHg respectively from 730 mmHg to 780 mmHg. 
For a desired dynamic range of 610 to 820 mmHg the first 
10 sensor undergoes a total phase change of similar to 4.8 
radians and the second sensor undergoes a total phase 
change similar to 16 radians. In this exemplary case the first 
sensor 101 provides a coarse measurement of pressure with 
In an embodiment shown in FIG. 14B, the second 
intraocular pressure sensor 101 has at least one of a different 
diameter, shape, flexible membrane 202 thickness, flexible 
membrane 202 material, and substrate member 200 material. 
The two or more pressure sensors 101 provide at least one 
of redundant pressure measurement, failure detection, com-
pensation for temperature fluctuations in the eye, increased 
pressure measurement precision, increased pressure mea-
surement dynamic range. In this embodiment, the flexible 
membrane 202 deflection due to temperature changes and 
the flexible membrane 202 deflection due to pressure 
changes are different for the two different sensors 101. Thus, 
the pressure and temperature can be separately measured by 
solving a set of simultaneous equations of the form: 
15 
no ambiguity over the entire pressure range, and the second 
sensor 101 provides a more sensitive measurement of pres-
sure with ambiguity among several pressures within the 
range. However, the first sensor 101 removes this ambiguity. 
Using two sensors 101 allows intraocular pressure to be 
20 measured with greater sensitivity without sacrificing 
dynamic range. Other sensor designs can be contemplated 
that would expand dynamic range without sacrificing sen-
sitivity. 
The anchoring member 500 is formed from materials that 
25 are biocompatible when implanted in the eye. Possible 
materials include polymethylmethacrylate, other acrylic 
plastics, and silicone. These materials are commonly used 
for intraocular lenses. In addition, biocompatible metals and 
where 81 and 82 are the phases for the interference pattern 30 
300 or the intensities associated with the fluorescence for the 
metal alloys containing elements such as gold or titanium 
are possible materials for the anchoring member. 
As discussed above, FIG. 2A shows an intraocular pres-
sure sensor 101 comprising a substrate member 200, a 
spacer member 201, a flexible membrane 202 which define 
a sealed cavity 203. The flexible membrane 202 deflects in 
first and second sensor respectively. 801 and 802 are known 
reference phases for the interference pattern 300 or known 
reference intensities associated with the fluorescence for the 
first and second sensor respectively. S1r and S2 r are the 
sensitivities of the first and second sensor to changes in 
temperature, for example in radians/° C. or intensity/° C., 
SIP and S2P are the sensitivities of the first and second sensor 
35 response in response to intraocular pressure changes and the 
deflection of the flexible membrane 202 can be measured 
to changes in pressure, for example in radians/mmHg or 
intensity/mmHg, T is the temperature and T0 is a known 40 
reference temperature, and P is the pressure and PO is a 
known reference pressure. 
optically. The substrate member 200 consists of at least one 
biocompatible metal, semiconductor, or insulator material. 
The spacer member 201 consists of at least one biocompat-
ible metal, semiconductor, or insulator material. The spacer 
member 201 prevents fluid from penetrating into the sealed 
cavity 203. In an embodiment the spacer member 200 
material is at least one of silicon, silicon nitride, and silicon 
dioxide. The spacer member 201 can be formed by one of 
45 several processes familiar to those skilled in the art of 
microfabrication including at least one of etching or depo-
An exemplary device with two intraocular pressure sen-
sors 101 includes one sensor with diameter similar to 300 
um and another with diameter similar to 400 um. The 
flexible membrane 202 thickness is similar to 1.5 µm for 
both sensors. The sensitivities of the two intraocular pres-
sure sensors 101 to changes in pressure are similar to 0.020 
radians/mmHg and 0.037 radians/mmHg respectively for 
intraocular pressure ranges from 730 mmHg to 780 mmHg 50 
(10 to 50 mmHg above atmospheric pressure at sea level). 
The sensitivity of the two sensors 101 to changes in tem-
perature are similar to 0.014 radians/° C. and 0.023 radians/0 
C. respectively. Thus, the interference patterns 300 from the 
two sensors allow differentiation between changes in pres- 55 
sure and temperature. 
In an embodiment, the flexible membrane 202 deflection 
due to pressure changes is different for two sensors 101. 
Pressure is determined by measuring the phase angles of the 
interference patterns 300 from both sensors. If the phase 60 
change for at least one of the interference patterns 300 
exceeds 2it the pressure can still be determined uniquely 
based on the phase of the other interference pattern. In 
addition, if the desired dynamic range is kept constant, the 
use of two sensors with higher sensitivity, but at least one 65 
with total phase change greater than 2it, can improve sen-
sitivity and thus sensing precision and accuracy. 
sition. 
In a preferred embodiment the sealed cavity 203 has a 
pressure below one atmosphere. The reduced cavity pressure 
reduces the temperature sensitivity of the device because 
expansion or contraction of the gas inside the cavity will not 
create large changes in the separation of the flexible mem-
brane 202 from the substrate member 200. A sealed cavity 
203 with reduced pressure can be formed by one of several 
processes familiar to those skilled in the art of microfabri-
cation including at least one of vacuum contact bonding, 
vacuum anodic bonding, vacuum adhesive bonding, thermal 
annealing, etching through release holes and low pressure 
chemical vapor deposition sealing of these holes, and get-
tering of residual gas in the cavity. 
The flexible membrane 202 is substantially impermeable 
to gas or liquid in order to maintain the integrity of the sealed 
cavity 203 over the life of the intraocular pressure sensor 
101. In a preferred embodiment, the flexible membrane 202 
consists of silicon nitride. Silicon nitride is one of the best 
known moisture and gas barriers, with no measurable per-
meation, even at 1100° C. 
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In an embodiment, an incident light 103 (FIG. 1) strikes 
the intraocular pressure sensor 101 and is partially reflected 
and partially transmitted by the flexible membrane 202. The 
transmitted light is partially reflected by the substrate mem-
ber 200. Reflected light from the flexible membrane 202 and 
the substrate member 200 combine to form a resultant light 
113. Light reflected by the substrate member 200 interferes 
either constructively or destructively with light reflected 
from the flexible membrane 202 to create an interference 
pattern 300 (FIG. 3). The resulting interference pattern 300 
corresponds to intraocular pressure, as described in more 
detail below. 
The substrate member 200 consists of a material with the 
correct optical properties and surface finish to at least 
partially reflect light at the illumination wavelength. The 
substrate member 200 material is chosen from a group 
including at least one ofbiocompatible metals, semiconduc-
tors, or insulators. In an embodiment, the substrate member 
200 is made of polished silicon which is partially reflective 
throughout the visible and near-infrared spectral region. In 
another embodiment the substrate member 200 is made from 
14 
absolute pressure (60 mmHg above atmospheric pressure at 
sea level) the flexible membrane 202 deflects similar to 3.6 
µm at its central point. This gives rise to 9 periods in the 
interference pattern 300 when illuminated with an incident 
5 light 103 of 800 nm wavelength. To measure intraocular 
pressure from 10 to 60 mmHg with respect to atmospheric 
pressure at elevations from sea level to 2000 m the sensor 
101 measures absolute pressures from 610 mmHg to 820 
mmHg. For a light source 102 emitting a single wavelength, 
10 the interference pattern 300 is limited to a maximum phase 
change of 2it over this pressure range. Thus the intraocular 
pressure measurement system 100 must measure the phase 
to ±0.03 radians to maintain an accuracy of 1 mmHg. With 
a signal to noise ratio as low as 1, the standard deviation of 
15 the phase estimate is similar to 0.01 radians when the signal 
is captured using only 200x200 pixel electronic image 
sensor. We define signal to noise ratio as the square of the 
amplitude of the interference pattern 300 modulation 
divided by the variance of an additive Gaussian noise. This 
20 noise level is much larger and the image resolution much 
smaller than what would be typically encountered in prac-
tice, thus the precision of the phase measurement is suffi-
cient to detect clinically relevant changes in intraocular 
a glass, plastic, semiconductor, or oxide material. In another 
embodiment, the substrate member 200 material is optically 
transparent for visible wavelengths but is reflective at infra-
red wavelengths. In another embodiment, the substrate 25 
member 200 is coated with another layer of material or 
multiple layers of materials to render it reflective in the 
infrared. In this way the sensor is transparent in the visible 
spectral region but reflective in the infrared region to 
improve the aesthetics of the sensor. 
pressure. 
The material and dimensions of the flexible membrane 
202 and the dimensions of the spacer layer 201 prevent the 
membrane 202 from contacting the bottom of the sealed 
cavity 203 under pressures encountered in the intraocular 
environment. In an exemplary sensor 101 the flexible mem-
30 brane 202 consists of non-stoichiometric, low-stress silicon 
nitride with an elastic modulus similar to 200 GPa and a The flexible membrane 202 consists of a material with the 
correct optical properties and correct thickness to partially, 
but not entirely, reflect an incident light 103. In this way an 
optical cavity is formed and an optical interference pattern 
300 is generated. In one embodiment a flexible membrane 35 
202 consists of at least one of silicon, silicon nitride, and 
silicon dioxide. A flexible membrane 202 can be formed by 
one of several processes familiar to those skilled in the art 
Poisson ratio similar to 0.27. The flexible membrane 202 
diameter is 300 µm and the flexible membrane 202 thickness 
is 1.5 µm. The sealed cavity 203 contains a vacuum. At 820 
mmHg absolute pressure (60 mmHg above atmospheric 
pressure at sea level) the flexible membrane 202 deflects 
similar to 3.6 µm toward the substrate member 200 at its 
center. If the spacer member 201 is greater than 3 .6 µm thick 
then the flexible membrane 202 will not contact the substrate of microfabrication including at least one of implantation, 
oxidation, physical vapor deposition, chemical vapor depo-
sition, and etching. 
40 member 200. Other dimensions and materials could be 
The interference pattern 300 consists of bright and dark 
regions that are often referred to as interference fringes. 
These interference fringes change position when the flexible 
membrane 202 deflects with respect to the substrate mem- 45 
ber. The separation of these rings depends on the curvature 
contemplated that also prevent contact between the flexible 
membrane 202 and the substrate member 200. 
In a preferred embodiment an intraocular pressure sensor 
101 limits pressure measurement errors to 1 mmHg in the 
presence of temperature fluctuations from 32° to 36°. This 
range represents the approximate range of corneal tempera-
ture variation for ambient temperatures ranging from 18° C. 
to 27° C. It is known that variations in corneal temperature 
represent an upper bound on variations in the anterior 
50 chamber. In an exemplary sensor 101 the flexible membrane 
202 consists of non-stoichiometric, low-stress silicon nitride 
with an elastic modulus similar to 200 GPa, a Poisson ratio 
similar to 0.27, and a coefficient of thermal expansion 
similar to 2.3xl o-6/° C. One skilled in the art of microfab-
of the flexible membrane 202 surface. If the separation of the 
flexible membrane 202 and the substrate member 200 
changes then the rings shift in radial position. If the curva-
ture of the flexible membrane 202 surface changes then the 
spacing of the rings changes. The visibility, the difference in 
intensity between brightest and darkest points divided by 
sum of the intensities between the brightest and darkest 
points, of the rings at the detector 106 is determined by the 
separation of the substrate member 200 and the flexible 55 
membrane 202 and the coherence length of the resultant 
light 113. 
The materials and dimensions of the flexible membrane 
allow a number of periods in the interference pattern 300 and 
sufficient deflection to detect clinically important changes in 
intraocular pressure. In it known that intraocular pressure 
changes of 1 mmHg have clinical significance in managing 
glaucoma. In an exemplary sensor the flexible membrane 
202 is circular with a diameter of 300 µm and a thickness of 
1.5 µm. The sealed cavity 203 contains a vacuum. The 
spacer member is greater than 5 µm thick but less than twice 
the coherence length of the incident light 103. At 820 mmHg 
rication will understand that the mechanical properties of 
silicon nitride thin films can vary depending on deposition 
conditions and stoichiometry, and that other mechanical 
properties could be contemplated that would yield similar 
behavior. The flexible membrane 202 diameter is 500 µm 
60 and the flexible membrane 202 thickness is 0.5 µm. The 
sealed cavity 203 contains a vacuum. The substrate member 
200 and the spacer member 201 consist of silicon with a 
coefficient of thermal expansion of2.6xl0- 6/° C. The spacer 
member is greater than 11 µm thick. The illumination 
65 wavelength is 800 nm. At a normal intraocular pressure of 
15 mmHg (735 mmHg absolute pressure at sea level) the 
pressure measurement error with change in temperature is 
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several polyp-xylylene) polymers with a refractive index 
similar to 1.6 and a thickness similar to 150 nm, and the 
illumination wavelength is similar to 800 nm. In this 
example the interference pattern 300 visibility improves 
similar to 0.12 mmHg/° C. This restricts the measurement 
error to less than ±0.25 mmHg under the anterior chamber 
temperature fluctuations described above. In an embodi-
ment, the intraocular pressure measurement system 100 
indicates the pressure measurement is potentially erroneous 
if extreme ambient temperatures are detected. In an embodi-
ment, the pressure sensor 101 is calibrated for extreme 
ambient temperatures. Other dimensions and materials could 
5 from 0.48 without the additional layer 204 to 0.75 with the 
additional layer 204 in place. Other materials with different 
refractive indices and thicknesses could be conceived to 
achieve a similar improvement. 
In the case of a single intraocular pressure sensor 101 be contemplated that also reduce temperature dependence to 
acceptable levels. 
In a preferred embodiment an intraocular pressure sensor 
101 has a spacer member 201 with a thickness that provides 
10 illuminated by a single wavelength of light, the phase 
change of the interference pattern 300 is restricted to the less 
than 2it over the range of pressures to be measured. In an 
exemplary sensor the flexible membrane diameter is 300 µm an interference pattern 300 without using a light source that 
relies on laser action. The coherence length of the incident 
light 103 must be longer than twice the thickness of the 15 
sealed cavity 203. The spacer member 201 has a thickness 
that ensures the separation of the flexible membrane 202 and 
the substrate member 200 is less than half the coherence 
length of the incident light 103. Laser light sources typically 
have coherence lengths of greater than 1 mm. However, eye 20 
safety concerns when using lasers indicate that a light 
emitting diode light source is preferred. Light emitting 
diodes have coherence lengths ranging from approximately 
1 µm to 1000 µm. In an embodiment, an optical filter 105 is 
used to further increase the coherence length of at least one 25 
of the incident light 103 or the resultant light 113. In an 
exemplary sensor the spacer member is less than 50 µm thick 
so that the separation between the flexible membrane 202 
and the substrate member 200 does not exceed 50 um and 
thus an incident light 103 with a coherence length of less 30 
than 25 µm can be used to form the interference pattern 300. 
For an infrared light source 102 with a center wavelength of 
800 nm this corresponds to a spectral bandwidth of approxi-
mately 25 nm. Other dimensions could be contemplated that 
also allow light sources 102 not employing laser action to be 35 
used. One skilled in the art of interferometry will understand 
that there are subtle differences in definition of coherence 
length and spectral bandwidth depending on the spectral 
shape of the light, the criterion for bandwidth, and the 
criterion for coherence. As such, one skilled in the art will 40 
understand that the numbers given are representative and 
that other criteria for coherence length could be conceived. 
In one embodiment, shown in FIG. 2B, the intraocular 
pressure sensor 101 further comprises one or more layers 
204 of additional material coated on the external side of the 45 
flexible membrane 202. This additional material has refrac-
tive index and thickness such that reflection from the mem-
brane 202 is substantially equal to the reflection from the 
substrate member 200. Equalizing the reflection from the 
membrane 202 and substrate member 200 provides the 50 
greatest interference pattern 300 visibility, where visibility is 
defined as the ratio of the differences in the maximum and 
minimum intensity in the interference pattern 300 to the sum 
and the flexible membrane thickness is 1.5 µm. The wave-
length of illumination is 800 nm. Over a range of absolute 
pressures from 610 mmHg to 820 mmHg the sensor's 101 
sensitivity is similar to 0.02 radians/mmHg and the inter-
ference pattern 300 undergoes a phase change of less than 
2it. As a result, there is no ambiguity in the pressure 
measurements between 610 mmHg and 820 mmHg. Other 
dimensions and materials for the flexible membrane 202 
could be contemplated that also restrict the phase change to 
2it over a desired pressure range. 
In the embodiment shown in FIG. 7A, the intraocular 
pressure sensor 101 further comprises a coating 700 con-
taining a fluorescent material on the substrate member 200. 
A light source 102 excites the fluorescent material of the 
coating 700 and the fluorescent material of the coating emits 
a light of a different second wavelength. The proximity of 
the flexible membrane 202 to the substrate member 200 
modulates the intensity of the emitted light of a different 
second wavelength and the detected intensity of the emitted 
light of the different second wavelength is used to determine 
the pressure. The coating 700 can be any material that is 
intrinsically fluorescent or that has been dyed with a fluo-
rescent component. An example coating could be a polymer, 
such as poly-methyl methacrylate (PMMA), dyed with 
fluorescent molecules, such as the near-infrared polymethine 
dyes. In an embodiment both the polymer and the dye are be 
transparent in the visible part of the spectrum for aesthetic 
reasons. In an embodiment, both excitation and emission 
wavelengths are in the near infrared to prevent the patient 
from seeing the incident light 103 or resultant light 113 
while the pressure is being measured. In another embodi-
ment shown in FIG. 7B, the intraocular pressure sensor 101 
further comprises a coating 700 containing a fluorescent 
material on the flexible membrane 202. 
The intensity of the resultant light 113 from the pressure 
sensor 101 is modulated based on several phenomena. First 
the intensity of incident light 103 that reaches the fluorescent 
coating 700 is modulated. This occurs because of wave 
optical effects typically described in terms of (1) interfer-
ence of optical reflections from the membrane surfaces, the 
fluorescent material surfaces, and the substrate and (2) of the maximum and minimum intensity. As a result, the 
signal to noise ratio of the captured interference pattern 300 
will be maximized if all other conditions are equal. It is 
important to note that for certain combinations of flexible 
membrane 202 thickness and refractive index the additional 
layer 204 is unnecessary because the reflection is intrinsi-
cally balanced. However, the thickness of the flexible mem-
brane 202 is often determined by the pressure range and 
sensitivity required, and cannot be freely adjusted based on 
optical considerations. In an exemplary intraocular pressure 
sensor 101 the substrate member 200 is silicon with refrac-
tive index similar to 3.7, the flexible membrane 202 is low 
stress silicon nitride with refractive index similar to 2.2 and 
thickness similar 350 nm, the additional layer 204 is one of 
55 optical near-field and evanescent coupling across the sealed 
cavity when the separation of the membrane and substrate 
are on the order of the wavelength of light. When light is 
transmitted through two or more partially reflective surfaces 
it can interfere constructively and destructively depending 
60 on the separation of the surfaces. As a result, the transmitted 
power in the resultant light 103 depends on the separation of 
the surfaces. In the pressure sensor 101 there are at least four 
partially reflected surfaces: the two surfaces of the flexible 
membrane 202; the interface of the fluorescent coating 700 
65 with the sealed cavity 203; and the interface of the substrate 
member 200 with the fluorescent coating 700. First, the 
transmission of incident light 103 to the fluorescent coating 
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700 is modulated by the separation between the flexible 
membrane 203, which is partially reflective, and the fluo-
rescent coating 700 on the substrate member 200. As the 
transmitted power at the excitation wavelength changes, the 
light emission from the fluorescent coating 700 is modulated 5 
as well. 
The same effects that modulate the intensity of incident 
light 103 reaching the fluorescent coating 700 also modu-
lates the resultant light 113. In addition, a significant fraction 
18 
angle of incident light 103 to reduce output dependence on 
the angle of illumination. Secondly, the scattering medium 
701 serves to extract light from the flexible membrane 202 
and the fluorescent coating 700 that would otherwise be 
trapped by total internal reflection. This both increases the 
total amount of light emitted by the sensor and alters the 
relationship between the amount of resultant light 113 and 
the flexible membrane 202-fluorescent coating 700 gap. 
In an alternative embodiment, shown in FIG. 7D, the 
10 scattering medium 701 is placed on the surface of the 
flexible membrane 202 inside the sealed cavity 203. This 
configuration can improve light extraction from the fluores-
cent material because the scattering medium 701 is in a 
of the light emitted by the fluorescent coating 700 is 
reflected back into the material by total internal reflection. If 
the refractive index of the fluorescent coating 700 is greater 
than the underlying substrate member 200, then this light is 
completely trapped in the fluorescent layer. In either case, 
the evanescent electric field from the internally reflected 15 
light extends a short distance beyond the interface between 
the fluorescent coating 700 and the sealed cavity 203. If the 
flexible membrane 203 is sufficiently close to the fluorescent 
coating 700 (separation similar to wavelength) then light 
that would otherwise be totally internally reflected in the 
fluorescent coating 700 will couple into the flexible mem-
brane 202. The strength of this coupling is strongly depen-
dent on the separation of the two layers; thus, a change in 
pressure that deflects the flexible membrane 202, alters the 
fluorescent membrane 202-fluorescent coating 700 separa-
tion, and the light emission. Moreover, light will be trapped 
in the flexible membrane 202 by total internal reflection. 
In an exemplary pressure sensor 101, a substrate member 
200 is coated with a fluorescent coating 700 with real 
refractive index 1.7 and that is sufficiently thick and absorb-
ing to absorb all of the excitation light. A flexible membrane 
202 is separated from the fluorescent coating 202 by a sealed 
cavity 203 containing vacuum. The pressure sensor 101 is 
excited with the incident light 113 at wavelength of 770 nm 
in the near infrared and the fluorescent coating 700 emits at 
800 nm. For explanatory purposes, the incident light 103 is 
normally incident, unpolarized, and collimated, and the 
fluorescence yield ( or quantum efficiency) is 1. The resultant 
light 113 emitted from the fluorescent coating 700 is unpo-
larized and has a diffuse (Lambertian) distribution. 
FIG. llA shows a calculated ratio of resultant light 113 
power to incident light 103 power as a function of membrane 
202-fluorescent coating 700 separation. This ratio is a direct 
measure of membrane 202 deflection and thus a measure of 
pressure. 
The pressure sensor 101 need not operate with collimated 
incident light 103 or with normally incident light 103. 
However, the output of the pressure sensor 101 is dependent 
on the angle of illumination, cp. 
FIG. llB shows a calculated ratio of resultant light 113 
power to incident light 103 power as a function of membrane 
202-fluorescent coating 700 separation with an illumination 
angle of 10 degrees from normal. The relationship is differ-
ent and this angle dependence must either be calibrated out 
of the pressure reading or eliminated by a more sophisticated 
sensor design described in more detail below. 
region of greater evanescent electric field strength. 
In an exemplary sensor a scattering medium 701 is coated 
on the flexible membrane 202 surface external to the sealed 
cavity 203. Both incident light 103 and emitted light are 
diffusely (Lambertian) scattered at the membrane surface. 
As a result, the ratio of incident light 103 power to resultant 
20 light 113 power is no longer dependent on angle of illumi-
nation. However, the angle of illumination will affect the 
total input power coupled into to the sensor. 
FIG. llC plots the calculated ratio ofresultant light 113 
power to incident light 103 power as a function of flexible 
25 membrane 202-fluorescent coating 700 separation with the 
scattering medium 701 on the external side of the flexible 
membrane 202. This relationship is independent of illumi-
nation angle. 
In an embodiment, the fluorescent coating 700 is placed 
30 in the flexible membrane 202, rather than on the substrate 
member 200, as shown in FIG. 7B. This embodiment is 
governed by the same phenomena; however, interference 
effects, near field effects, and evanescent coupling are all 
modified by the position of the fluorescent coating 700 in 
35 relation to the other sensor components. Specifically, light is 
trapped in the combined structure of the fluorescent coating 
700 and the flexible membrane 202, and is evanescently 
coupled to the substrate member 200 depending on the 
40 
fluorescent coating 700-substrate member 200 separation. 
In another embodiment of the exemplary intraocular 
pressure sensor 101, two different fluorophors are contained 
in the fluorescent coating 700, and the two fluorophors emit 
light at two different wavelengths. The detector 106 mea-
sures the ratio of optical power at the two different wave-
45 lengths. In an embodiment the detector comprises a dichroic 
beam splitter and two light sensors. Each light sensor detects 
only one wavelength. In another embodiment, the detector 
comprises a beam splitter, two optical filters, and two light 
sensors. Again, each light sensor detects only one wave-
50 length. By measuring the difference in detected optical 
power between the two sensors, the pressure measurement 
system 101 can compensate for different excitation and 
emission efficiencies that occur when the eye moves relative 
to the light source 102 and the detector 106 during or 
55 between measurements. 
In an exemplary sensor 101 the fluorescent coating 700 
emits at two wavelengths, 800 nm and 900 nm. When both 
fluorophors are excited, the ratio of the detected intensity 
between the two wavelengths corresponds to intraocular 
60 pressure. In this way we need not know the excitation power 
for any given measurements. 
In an embodiment shown in FIG. 7C, the flexible mem-
brane 203 is also coated with a scattering medium 701 on the 
side of the membrane external to the sealed cavity 203 to 
enhance light emission from the sensor 101 and minimize 
illumination angle dependence, as further described below. 
An example of such a scattering medium is polytetrafluo-
roethylene. Modulation of the incident light 103 reaching 
the fluorescent layer and modulation of the resultant light 
113 exiting the sensor are both governed by the phenomena 65 
described above. The scattering medium 701 serves two 
purposes. First the scattering medium 701 randomizes the 
FIG. llD plots the ratio oflight detected at 800 nm to that 
detected at 900 nm as a function of the flexible membrane 
202-fluorescent coating 700 separation. 
As shown in FIG. 12, an exemplary method 1200 for 
determination of intraocular pressure, includes the steps of: 
S1202 placing an intraocular pressure sensor 101 (FIG. 1) in 
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an eye (e.g., eye 505 of FIG. 5B), the intraocular pressure 
sensor 101 including a substrate member 200, a spacer 
member 201, and a flexible membrane 202, the substrate 
member 200, the spacer member 201 and the flexible 
membrane 202 defining a sealed cavity 203 wherein the 5 
flexible membrane 202 moves and/or deforms in response to 
intraocular pressure changes; S1204 illuminating, with a 
light source 102, the intraocular pressure sensor 101 with 
one or more wavelengths oflight; and S1206 detecting, with 
a detector, a resultant light that contains information about 10 
intraocular pressure. 
20 
In an embodiment, immobilizing the intraocular pressure 
sensor in the eye further includes suturing the plate 502 to 
the eye using holes 504 in the plate 502. 
As shown in FIG. 13, an exemplary method 1300 for the 
determination of pressure from an interference pattern 300 
produced by an intraocular pressure sensor 101 comprising 
a substrate member 200; a spacer member 201; and a flexible 
membrane 202; the substrate member 200, the spacer mem-
ber 201 and the flexible membrane 202 defining a sealed 
cavity 203; wherein the flexible membrane 202 moves 
and/or deforms in response to intraocular pressure changes 
and the movement or deformation of the flexible membrane 
202 is measured optically, wherein light from a light source 
102, emitting one or more wavelengths of light either 
simultaneously or sequentially, is both transmitted and 
reflected by the flexible membrane 202, and reflected by the 
substrate member 200, and wherein the light reflected by the 
substrate member 200 interferes with light reflected from the 
In an embodiment, the flexible membrane 202 (FIG. 2) 
both transmits and reflects the one or more wavelengths of 
light, the substrate member 200 reflects the one or more 
15 
wavelengths of light transmitted by the flexible membrane 
202, the light reflected by the substrate member 200 inter-
feres with light reflected from the flexible membrane 202 to 
create an interference pattern 300, and the interference 
pattern 300 corresponds to intraocular pressure. 20 flexible membrane 202 to create an interference pattern 300, 
the method includes the steps of: S1302 performing, by a 
processing device 107, a phase calculation on the interfer-
ence pattern 300 to determine phase angles of the interfer-
ence pattern 300; and S1304 correlating the phase angles 
In an embodiment, the step S1206 detecting the resultant 
light includes capturing, with an electronic imaging device, 
an image of the interference pattern 300, and the method 
further comprises a step S1208 performing a phase calcu-
lation on the image of the interference pattern 300 to 25 
determine phase angles of the interference pattern 300; and 
a step S1210 correlating the phase angles with intraocular 
pressure. 
with pressure. 
An exemplary interference pattern 300 has intensity, I, 
that is periodic with the square of the spatial variables. An 
exemplary signal of this type is I(x, y)=A cos(k,x2 +kyy2)+B 
where A is the amplitude of the fringe modulation, ~ and Is, 
In an embodiment, the method further comprises a step 
S1212 positioning an optical filter 105 between the intraocu-
lar pressure sensor 101 and at least one of the light source 
102 and the electronic imaging device, the optical filter 105 
providing an optical coherence length greater than twice the 
distance from the flexible membrane 202 to the substrate 
member 200. 
30 are the spatial frequencies of the rings in the x- and y-di-
rections, x and y are the spatial coordinates across the sensor 
surface, and B is constant offset of zero light level. In 
practice, this signal may be discretely sampled by an elec-
tronic imaging device so that the pixel value at the j th ,kth 
In an embodiment, the step of S1204 illuminating the 
intraocular pressure sensor includes modulating the light 
source 102 in time to allow for lock-in detection of the 
interference pattern 300 by the electronic imaging device. 
35 location in the image matrix is given by I1k=A cos(~x/ + 
kyy/)+B. 
To determine the phase of the interference pattern 300, the 
two-dimensional image is multiplied by a kernel of the form 
K(kx,ky,x, y)=exp [-ikxx2 -i]s, y2 ]. For each value of~ and 
In an embodiment, the method further comprises a step 
S1214 coating a coating 700 containing fluorescent material 
40 kY the product of the signal and kernel is integrated over x 
and y to yield the integral transform given by :S(~,]s,)=Jjl(x, 
y)exp [-j~x2 -jkyy2]dxdy. FIG. 3B shows the absolute value 
of the integral transform 302, IF(kx,ky)I. As can be seen in 
FIG. 3B, there is a peak value 301 in IF(~,]s,)I at a particular 
on at least one of the substrate member 200 and the flexible 
membrane 202, wherein the step S1204, illuminating the 
intraocular pressure sensor, includes exciting the fluorescent 
material of the coating 700 with a light source 102 such that 
the fluorescent material of the coating 700 emits a light of a 
different second wavelength, the emission of the light of the 
second wavelength being the result of excitation of the 
fluorescent material, wherein the proximity of the flexible 50 
membrane 202 to the substrate member 200 modulates the 
intensity of the resultant light 113 of a different second 
wavelength, and wherein the step S1206 detecting the resul-
tant light, includes detecting an intensity of the resultant 
light 113 of the different second wavelength to determine the 55 
45 non-zero pair of values for~ and ky- At this peak value 301, 




!/J(kx, ky) = arctan Re{F(kx, ky)) , 
will relate to how the rings are spatially positioned. Because 
the spatial position of the rings in the interference pattern 
300 is related to the deflection of the flexible membrane 202 
with respect to the substrate member 200, one can determine 
intraocular pressure from the phase of the transform at the 
In an embodiment, the step S1202, placing the intraocular 
pressure sensor in an eye, further includes immobilizing the 
intraocular pressure sensor 101 in the eye 505 using an 
anchoring member 500 attached to the intraocular pressure 
sensor 101. 
spatial frequencies corresponding to the peak 301. A change 
in the phase of the transform indicates a shift in position of 
the rings and thus a change in pressure. In an embodiment, 
60 the transform is computed discretely and becomes 
In an embodiment, the anchoring member 500 comprises 
a plate 502 and an arm 503, and immobilizing the intraocular 
pressure sensor 101 further includes inserting the plate 502 
into a scleral pocket of the eye 505; and inserting the arm 65 
503 into an anterior chamber 506 of the eye through a scleral 
tunnel. 
N M 
r(kx, ky) = ~ ~ 11,exp[-ikxx] -
j=O k=O 
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where N is the number of pixels in the x-direction and Mis 
the number of pixels in the y-direction. 
22 
ously illuminated with wavelengths of 700 nm and 900 nm. 
In this case the two wavelengths result in a peak 1000 for 
900 nm and a peak 1001 for 700 nm in a single integral 
transform. The shorter wavelength yields a higher spatial 
In an embodiment, the spatial frequencies are known and 
the transform need only be computed for one value ofkx and 
one value of ]s,. In an embodiment, the spatial frequencies 
are not known, and the integral transform is computed for a 
range of spatial frequencies, the peak 301 in the absolute 
value of the integral transform 302 is identified, and the 
phase is computed at the spatial frequencies corresponding 
to the peak 301. 
5 frequency. The two phases associated with the two wave-
lengths can be used to track phase changes larger than 2it 
without ambiguity in the relationship between phase and 
pressure. This method can increase the dynamic range of a 
sensor or allow a certain dynamic range to be maintained 
10 while redesigning the sensor for greater sensitivity. 
Thus, the invention provides systems, devices, and meth-
ods for measuring intraocular pressure. One of ordinary skill 
in the art will recognize that additional steps and configu-
rations are possible without departing from the teachings of 
FIG. 3C plots the phase at the peak 301 of IF(kx,ky)I as a 
function of pressure for experimentally obtained data. The 
sensor was placed in a sealed chamber with water around it, 
and the pressure was varied with a syringe. The pressure 
values on the abscissa were measured with a commercial 
analog pressure sensor placed in the same test chamber as 
the optical sensor. It is apparent that phase is correlated with 
pressure, and that the sensor covers a range of physiologi-
cally relevant pressures found in the human eye (5-30 
mmHg). In addition, this sensor design covers this range of 
pressures relative to atmospheric pressure without exceed-
ing a phase change of 2it and there is no ambiguity in the 
phase-pressure relationship. 
15 the invention. This detailed description, and particularly the 
specific details of the exemplary embodiment disclosed, is 
given primarily for clearness of understanding and no 
unnecessary limitations are to be understood therefrom, for 
modifications will become evident to those skilled in the art 
20 upon reading this disclosure and may be made without 
departing from the spirit or scope of the claimed invention. 
In an embodiment, the normal axis of the intraocular 
pressure sensor 101 is not required to be coincident with the 25 
optical axis of at least one of the light source 102 and 
detector 106. The interference pattern 300 is spatially com-
pressed along the direction associated with the tilt angle of 
the sensor 101. For example, if the patient looks to the side 
during a pressure measurement, the sensor 101 will rotate 30 
about the y-axis and the interference pattern 300 will appear 
to compress in the x-direction. Compression of the interfer-
ence pattern 300 in space shifts the peak 301 in IF(kx,ky)I to 
a higher spatial frequency. Thus, one can determine the 
angle of the sensor 101 with respect to the optical axis of the 35 
readout system from the values ofkx and ky- This allows one 
to correct for any error that would otherwise be introduced 
by the patient not looking directly along the optical readout 
axis. FIG. 4A shows an interference pattern 300 with the 
sensor rotated by 25 degrees about its y-axis. This rotation 40 
is extreme, but is used for exemplary purposes to make the 
fringe compression appear clear by visual inspection. FIG. 
4B shows the absolute value of the integral transform 302, 
IF(~,]s,)I. In this case, the peak 301 shifts to higher values 
of kx because of the rotation. 45 
In an embodiment, at least one of a larger range of 
pressures needs to be measured or greater sensitivity, i.e. 
phase change with change in pressure, is required. Two 
wavelengths of light illuminate the sensor 101. In an 
embodiment, the wavelengths illuminate the sensor sequen- 50 
tially so the interference pattern 300 from each wavelength 
is measured separately. FIG. 9A and FIG. 9B show two 
interference patterns 300 for sequential measurement of a 
sensor with wavelengths of700 nm and 900 nm respectively. 
FIG. 9C and FIG. 9D show the absolute value of the integral 55 
transforms 302 for 700 nm and 900 nm wavelengths respec-
tively. The peak values 301 occur at different spatial fre-
quencies for the two different wavelengths. Calculating the 
phase at the spatial frequencies corresponding to each peak 
301 in each transform allow unambiguous determination of 60 
the pressure even if the phase change of one or both 
interference patterns 300 exceeds 2it. 
In an embodiment, the two wavelengths illuminate the 
sensor simultaneously, and a single interference pattern 300 
is captured by the detector 106. FIG. l0A shows the inter- 65 
ference pattern 300 and FIG. 10B shows the absolute value 
of its integral transform 302 when the sensor is simultane-
What is claimed is: 
1. An intraocular pressure sensor for implantation in an 
eye, comprising: 
a substrate member; a spacer member; and a flexible 
membrane; 
the substrate member, the spacer member and the flexible 
membrane forming the walls of a sealed cavity having 
no openings for fluid communication with a vacuum, 
and forming the intraocular pressure sensor configured 
for implantation in the eye; 
the flexible membrane configured to deform in response 
to intraocular pressure changes and wherein the defor-
mation of the flexible membrane can be measured 
optically; 
the flexible membrane configured to partially transmit and 
partially reflect an incident light that is incident on an 
exterior surface of the flexible membrane when the 
intraocular pressure sensor is implanted in the eye, and 
the substrate member configured to reflect the incident 
light that is partially transmitted by the flexible mem-
brane back through the flexible membrane; 
wherein the incident light reflected by the substrate mem-
ber interferes with incident light reflected by the flex-
ible membrane to create a resultant light comprising an 
interference pattern consisting of bright and dark rings 
having a separation depending on a curvature of the 
flexible membrane; 
wherein the resulting interference pattern is capturable as 
an image using a camera and corresponds to intraocular 
pressure; and wherein the sealed cavity has a pressure 
below one atmosphere. 
2. The intraocular pressure sensor of claim 1, wherein the 
material dimensions of the flexible membrane provide a 
number of periods in the interference pattern to estimate 
phase within ±0.03 radians such that intraocular pressure can 
be measured with an accuracy of 1 mm Hg over a range of 
610 to 820 mmHg absolute pressure. 
3. The intraocular pressure sensor of claim 1, the material 
and dimensions of the flexible membrane configured to 
prevent the membrane from contacting the bottom of the 
sealed cavity under pressures encountered in the intraocular 
environment. 
4. The intraocular pressure sensor of claim 1, the materials 
and dimensions of the flexible membrane configured to limit 
pressure measurement errors to less than 1 mm Hg in the 
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presence of temperature fluctuations from 32° C. to 36° C. 
encountered in the intraocular environment. 
5. The intraocular pressure sensor of claim 1, wherein the 
material and dimensions of the flexible membrane and the 
thickness of the spacer member provide the interference 5 
pattern without using a light source that relies on laser 
action. 
6. An intraocular pressure sensor for implantation in an 
eye, comprising: 
a substrate member; a spacer member; and a flexible 10 
membrane; 
the substrate member, the spacer member and the flexible 
membrane forming the walls of a sealed cavity having 
no openings for fluid communication with a vacuum, 
and forming the intraocular pressure sensor configured 15 
for implantation in the eye; 
the flexible membrane configured to deform in response 
24 
the substrate member configured to reflect the incident 
light that is partially transmitted by the flexible mem-
brane back through the flexible membrane; 
wherein the incident light reflected by the substrate mem-
ber interferes with incident light reflected by the flex-
ible membrane to create a resultant light comprising an 
interference pattern consisting of bright and dark rings 
having a separation depending on a curvature of the 
flexible membrane; and 
wherein the resulting interference pattern is capturable as 
an image using a camera and corresponds to intraocular 
pressure; and 
further comprising a layer of additional material coated on 
the external side of the flexible membrane, the thick-
ness and refractive index of the additional material 
configured to equalize the incident light reflected by the 
substrate member and the incident light reflected by the 
flexible membrane. 
to intraocular pressure changes and wherein the defor-
mation of the flexible membrane can be measured 
optically; 20 7. The intraocular pressure sensor of claim 1, the material 
and dimensions of the membrane configured to limit the 
phase change in the interference pattern to less than 2it over 
a range of 610 to 820 mmHg absolute pressure. 
the flexible membrane configured to partially transmit and 
partially reflect an incident light that is incident on an 
exterior surface of the flexible membrane when the 
intraocular pressure sensor is implanted in the eye, and * * * * * 
